HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A congenital myasthenic syndrome refractory to acetylcholinesterase inhibitors.

Abstract
We studied 4 siblings (3 men and 1 woman), ages 22 to 43 years, with congenital ptosis, external ophthalmoplegia, proximal muscle weakness and fatigability unresponsive to acetylcholinesterase (AChE) inhibitors. Repetitive nerve stimulation showed a significant compound muscle action potential (CMAP) area decrement at 2 or 3 Hz. Nerve conduction studies and concentric needle electromyography were normal, and repetitive CMAPs to single nerve stimulation were not observed. Voluntary single fiber electromyography (SFEMG) showed increased jitter and blocking. Assessment of individual end-plates using SFEMG with intramuscular axonal microstimulation showed no uniform relationship between jitter and the rate of stimulation, consistent with a postsynaptic defect of neuromuscular transmission. Edrophonium eliminated the decremental response to repetitive nerve stimulation, but caused no significant clinical improvement, suggesting an additional mechanism for weakness in these patients.
AuthorsW J Triggs, A Beric, I J Butler, S M Roongta
JournalMuscle & nerve (Muscle Nerve) Vol. 15 Issue 3 Pg. 267-72 (Mar 1992) ISSN: 0148-639X [Print] United States
PMID1313543 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cholinesterase Inhibitors
  • Receptors, Cholinergic
  • Edrophonium
Topics
  • Adult
  • Cholinesterase Inhibitors (therapeutic use)
  • Edrophonium
  • Electromyography
  • Female
  • Genes, Recessive
  • Humans
  • Male
  • Myasthenia Gravis (congenital, drug therapy, genetics)
  • Neuromuscular Junction (physiology)
  • Receptors, Cholinergic (analysis)
  • Roma
  • Synaptic Transmission (physiology)
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: